Pharmacovigilance

Global Market Trajectory & Analytics

MCP22511

EXECUTIVE ENGAGEMENTS

POOL

842
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

168
Interactions with Platform & by Email

PARTICIPANTS

34
Unique # Participated

VALIDATIONS

9
Responses Validated*

COMPANIES

32
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

411

PAGES

473

EDITION

4

PRICE

USD 5600

CODE

MCP22511


COMPETITIVE METRICS

COMPANY

D S N T

% *

4C Pharma

AB Cube

Accovion

APCER Life Sciences

Archimed Medical Communication

ArisGlobal LLC

Atlassian Pty., Ltd.

Axpharma

Azidus

Basic Pharma

*Login to Participate & View Data Stacks
View 32 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Pharmacovigilance estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$11.8 Billion by 2027, growing at aCAGR of 11.9% over the period 2020-2027. Contract Outsourcing, one of the segments analyzed in the report, is projected to record 13.1% CAGR and reach US$7.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the In-House segment is readjusted to a revised 10% CAGR for the next 7-year period.
The Pharmacovigilance market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.6 Billion by the year 2027 trailing a CAGR of 15.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.3% and 10.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.4% CAGR.

SELECT PLAYERS

Accenture; ArisGlobal; BioClinica Inc.; Capgemini; Cognizant; FMD K&L; IBM Corporation; ICON Plc; IQVIA; ITClinical; Laboratory Corporation of America Holdings; Linical Accelovance; Parexel International Corporation; TAKE Solutions Ltd.; United BioSource Corporation; Wipro Ltd.

SEGMENTS

» Service Provider (Contract Outsourcing, In-House) » Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining) » Therapeutic Area (Oncology, Neurology, Cardiology, Respiratory Systems, Other Therapeutic Areas) » End-Use (Pharma Companies, Biotech Companies, Medical Device Manufacturers, Other End-Uses)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Pharmacovigilance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmacovigilance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmacovigilance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Contract Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Contract Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Contract Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for In-House by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for In-House by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for In-House by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Respiratory Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Respiratory Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Respiratory Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Spontaneous Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Spontaneous Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Spontaneous Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Intensified ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Intensified ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intensified ADR Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Targeted Spontaneous Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Targeted Spontaneous Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Targeted Spontaneous Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Cohort Event Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Cohort Event Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cohort Event Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for EHR Mining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for EHR Mining by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for EHR Mining by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
China Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
China Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
China Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Pharmacovigilance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmacovigilance by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmacovigilance by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
France Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
France Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
France Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Pharmacovigilance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmacovigilance by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmacovigilance by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
India Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
India Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
India Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
India Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Pharmacovigilance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmacovigilance by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmacovigilance by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Pharmacovigilance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmacovigilance by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmacovigilance by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmacovigilance by Service Provider - Contract Outsourcing and In-House Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmacovigilance by Service Provider - Percentage Breakdown of Value Sales for Contract Outsourcing and In-House for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmacovigilance by Therapeutic Area - Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmacovigilance by Therapeutic Area - Percentage Breakdown of Value Sales for Cardiology, Respiratory Systems, Other Therapeutic Areas, Oncology and Neurology for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmacovigilance by End-Use - Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmacovigilance by End-Use - Percentage Breakdown of Value Sales for Pharma Companies, Biotech Companies, Medical Device Manufacturers and Other End-Uses for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Pharmacovigilance by Type - Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Pharmacovigilance by Type - Percentage Breakdown of Value Sales for Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring and EHR Mining for the Years 2012, 2020 & 2027
Total Companies Profiled: 32

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com